21.03.2018 08:54:03
|
Notice Convening the Annual General Meeting
March 21, 2018
Announcement no. 6
Notice Convening the Annual General Meeting
The Board of Directors hereby convenes the Annual General Meeting of BioPorto A/S:
April 13, 2018, at 3.00 pm (CET),
At the Company’s address
Tuborg Havnevej 15, st., DK-2900 Hellerup
(Parking in Waterfront Shopping)
Agenda:
- Report of the Company’s activities during the past year
- Presentation of the annual report for approval and allocation of profit or covering of loss
- Resolution to grant discharge of liability to the Board of Directors and Executive Management
- Approval of remuneration for the Board of Directors
- Election of members to the Board of Directors
- Proposals from the Board of Directors
A) Proposal to amend article 18 in the Articles of Association to renew the authorisation to issue warrants - Election of auditor
- Any other business
BioPorto A/S
The Board of Directors
Further information:
Gry Husby Larsen
Tel. no. (+45) 45 29 00 00, e-mail investor@bioporto.com
2018 03 21 - Notice to convene - BioPorto AGM 2018
![](https://images.finanzen.at/images/unsortiert/wertpapierdepot-absichern-aktienchart-boerse-750493204-260.jpg)
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Bioporto A-Smehr Nachrichten
29.01.25 |
BioPorto A/S appoints new interim Chairman of the Board (GlobeNewswire) | |
16.12.24 |
BioPorto commences process to appoint new Chair of the Board of Directors (GlobeNewswire) | |
13.11.24 |
Ausblick: Bioporto A-S stellt das Zahlenwerk zum vergangenen Quartal vor (finanzen.net) | |
30.10.24 |
Erste Schätzungen: Bioporto A-S stellt Ergebnisse des abgelaufenen Quartals vor (finanzen.net) | |
29.10.24 |
First Patient In - BioPorto Initiates Patient Enrollment for US Study of ProNephro AKI (NGAL)™ for Adult Use at Massachusetts General Hospital (GlobeNewswire) | |
28.10.24 |
BioPorto Enters Global Distribution Partnership with Beckman Coulter for Acute Kidney Injury NGAL Tests (GlobeNewswire) |
Analysen zu Bioporto A-Smehr Analysen
Aktien in diesem Artikel
Bioporto A-S | 1,50 | -1,05% |
|